CEEISCAT shares the results of the TÉSTATE project on HIV and hepatitis C
Two studies by CEEISCAT-IGTP have evaluated an online HIV and HCV self-testing strategy, demonstrating that it is effective and safe.
At the IGTP TODAY
News
CEEISCAT celebrates its 6th Annual Conference, focusing on transdisciplinary research in vulnerable populations
The event took place at CosmoCaixa Barcelona and featured contributions from health professionals, institutions, and entities that have been collaborating closely with the centre for many years.
The third IGTP Scientific Retreat proves a success
The IGTP Retreat consolidates as a nexus of the research carried out at the Can Ruti Campus. This year the event has focused on ageing and a patient-centred model of care.
- Research
A study by IDIBELL, ICO and IGTP puts precision medicine at the service of nerve tumors
A research team, led by Dr. Conxi Lázaro, from IDIBELL and ICO, and Dr. Eduard Serra, from IGTP, has published in the journal Molecular Oncology the expansion of a precision medicine platform to analyse and improve treatments for malignant peripheral nerve sheath tumours.
- Research
New guidelines for parasite studies using extracellular vesicles
A collaborative document outlining new guidelines for the isolation and characterisation of extracellular vesicles in parasitic disease research has been published in the Journal of Extracellular Biology. A research group from IGTP and ISGlobal contributed to the study, which could enhance our understanding of host-parasite interactions and advance early diagnosis, treatment, and prevention of parasite-caused diseases.
- Research
Apotransferrin shows promise as an early treatment for stroke
Researchers from IGTP have discovered that administering human apotransferrin to mice models affected by intracerebral haemorrhage can mitigate the damaging effects of this severe type of stroke. This finding highlights the promising role of apotransferrin as a pre-hospital and pre-triage frontline treatment for all stroke patients. The study has been published in the journal Antioxidants.
Medical and research staff at the Can Ruti Campus, once again among the world’s most prominent in the scientific field
The Can Ruti Campus and the healthcare and research teams of the different institutions that comprise it continue to prove, once again this year, to be a relevant node on a global scale in terms of scientific production and progress.
- Research
Type 1 diabetes research sheds light on biomarkers in partial remission phase
Researchers from the IGTP have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes, in collaboration with experts in β-cell biology and regeneration from the Diabetes Research Institute in Miami. The study has been published in the journal Trends in Endocrinology and Metabolism.
GCAT takes part in one of the projects funded by Fundació La Marató de 3Cat
The funds raised in the 2022 edition of La Marató de 3Cat will enable 71 research teams to conduct 37 projects in cardiovascular health to advance in the prevention, diagnosis, and treatment of diseases that represent the leading cause of death in developed countries. One of the awarded projects involves the participation of researchers from the GCAT of the IGTP, and is coordinated by Dr Camille Lassale from ISGlobal.
- Research
Agarose-based method shows potential in understanding extracellular vesicles' role in cancer metastasis
A collaborative study led by researchers from IGTP has revealed the promising possibilities of using an agarose spot migration assay to examine the ability of extracellular vesicles to attract other cells in a controlled environment. The study has been recently published in the journal BMC Biology.
